Viewing Study NCT02784860


Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2025-12-26 @ 3:08 AM
Study NCT ID: NCT02784860
Status: COMPLETED
Last Update Posted: 2018-01-03
First Post: 2016-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effects of Intravenous Lidocaine During Sedation for Colonoscopy.
Sponsor: University of Liege
Organization:

Study Overview

Official Title: Investigation of the Effects of Intravenous Lidocaine Infusion During Sedation for Colonoscopy
Status: COMPLETED
Status Verified Date: 2017-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study assesses the benefits of continuous intravenous lidocaine administration during sedation for colonoscopy.

Sedation will consist of propofol infusion titrated to provide adequate working conditions to the gastroenterologist. Patients will be randomly allocated into two groups: lidocaine infusion (bolus of 1.5 mg/kg followed by a continuous infusion of 4 mg/kg/h) or the same volume of placebo (normal saline)
Detailed Description: The potential benefits of lidocaine infusion will be tested on:

* propofol consumption (primary outcome)
* intraoperative respiratory depression
* time for patient recovery
* postoperative fatigue
* postoperative pain
* postoperative cognitive dysfunction

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: